Skip to main content
Log in

Combined Discrete-event Simulation and Ant Colony Optimisation Approach for Selecting Optimal Screening Policies for Diabetic Retinopathy

  • Original Paper
  • Published:
Computational Management Science Aims and scope Submit manuscript

Abstract

In this paper we present the first application to a healthcare problem of discrete-event simulation (DES) embedded in an ant colony optimisation (ACO) model. We are concerned with choosing optimal screening policies for retinopathy, a sight-threatening complication of diabetes. The early signs of retinopathy can be detected by screening before the patient is aware of symptoms, and blindness prevented by laser treatment. In this paper we describe the methodology used to combine the purpose-written DES model with the ACO algorithm. We simulate the effects of different screening strategies on a population of diabetic patients, and compare them in terms of two objective functions: Min C/E, cost-effectiveness (minimum incremental cost per year of sight saved, compared with a no-screening baseline) and Max E, maximum effectiveness (years of sight saved). We describe how ACO is used to optimise these two objectives, and discuss the issues involved in optimising stochastic variables. We present results for a range of different assumptions and scenarios about the format of screening programmes, using realistic data, and make policy recommendations on the basis of our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Brailsford SC, Davies R (2001) Screening for diabetic retinopathy, www.management.soton.ac.uk/ retinopathy, accessed 13 December 2005

  • Brailsford SC, Davies R, Canning C, Roderick PJ (1998) Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes. Health Care Manage Sci 1:115–124

    Article  Google Scholar 

  • British Multicentre Study Group (1975) Photocoagulation in treatment of diabetic maculopathy. The Lancet 2(7945):1110–1113

    Google Scholar 

  • British Multicentre Study Group (1984) Photocoagulation for proliferative diabetic retinopathy: a randomised controlled trial using the xenon-arc. Diabetologia 26:109–115

    Article  Google Scholar 

  • Brown MB, Brown GC, Sharma S, Shah G (1999) Utility values and diabetic retinopathy. Am J Ophthalmol 128:324–330

    Article  Google Scholar 

  • Cooper K, Davies R, Roderick P, Chase D, Raftery J (2002) The development of a simulation model of the treatment of coronary heart disease. Health Care Manage Sci 5:259–67

    Article  Google Scholar 

  • Crijns H, Casparie AF, Hendrikse F (1999) Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy. Int J Technol Assess Health Care 15:198–206

    Article  Google Scholar 

  • Davies R, Brailsford SC (2004). Screening for diabetic retinopathy. In: Handbook of OR/MS applications in health care. Sainfort F, Brandeau M, Pierskalla W (Eds). International series in operations research and management science. Kluwer, Norwell Mass, pp. 493–518.

  • Davies R, Davies HTO (1994) Modelling patient flows and resource provision in health systems. Omega Int J Manage Sci 22:123–131

    Article  Google Scholar 

  • Davies HTO, Davies R (1995) Simulating health systems: modelling problems and software solutions. Eur J Oper Res 87:35–44

    Article  Google Scholar 

  • Davies R, Brailsford SC, Roderick PJ, Canning C, Crabbe DN (2000) Using simulation modelling for evaluating screening services for diabetic retinopathy. J Oper Res Soc 51:476–484

    Article  Google Scholar 

  • Davies R, Roderick PJ, Canning C, Brailsford SC (2002) The evaluation of screening policies for diabetic retinopathy using simulation. Diabet Med 19:762–770

    Article  Google Scholar 

  • Department of Health (1991) The state of the nation. HMSO, London

    Google Scholar 

  • Dorigo M, Di Caro G (1999). The ant colony optimisation metaheuristic. In: Corne D, Dorigo M, Glover F (eds). New ideas in optimisation. McGraw-Hill, New York, pp. 11–33

    Google Scholar 

  • Dorigo M, Maniezzo V, Colorni A (1991) The ant system: an autocatalytic optimisation process. Technical Report 91–016, Department of Electronics Polytechnico di Milano, Italy

    Google Scholar 

  • Dorigo M, Maniezzo V, Colorni A (1996) The ant system: optimisation by a colony of cooperating agents. IEEE Trans Syst Man Cybern 26:1–13

    Google Scholar 

  • Eastman RC, Javitt JC, Herman WC, Dasbach EJ, Zbrozek AS et al (1997a) Model of complications of NIDDM, I. Model construction and assumptions. Diabet Care 20:725–734

    Google Scholar 

  • Eastman RC, Javitt JC, Herman WC, Dasbach EJ, Zbrozek AS et al (1997b) Model of complications of NIDDM II, analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycaemia. Diabet Care 20:735–744

    Google Scholar 

  • Gutjahr WJ (2000) A graph-based Ant System and its convergence. Future Generation Comput Syst 16: 873–882

    Article  Google Scholar 

  • Gutjahr WJ (2003). A converging ACO algorithm for stochastic combinatorial optimisation. In: Albrecht A, Steinhöfl K (eds). Proceedings of SAGA 2003 (Stochastic Algorithms: Foundations and Applications). Springer, Berlin Heidelberg New York, pp. 10–25

  • Gutjahr WJ (2004). S-ACO: An ant-based approach to combinatorial optimisation under uncertainty. In: Dorigo, Birattari, Blum, Gambardelle, Mondada, Stützle (eds). Proceedings of ANTS 2004 (4th international workshop on ant colony optimisation and swarm intelligence. Brussels, Springer, Berlin Heidelberg New York, pp 238–249

  • Harper PR, Sayyad MG, De Senna V, Shahani A, Yajnik CS et al (2003) A systems modelling approach for the prevention and treatment of diabetic retinopathy. Eur J Oper Res 150:81–91

    Article  Google Scholar 

  • Hutchinson A, McIntosh A, Peters J, O’Keefe C, Khunti K et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy - systematic review. Diabetics 17:495–506

    Article  Google Scholar 

  • James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Bri Med J 320:627–1631

    Google Scholar 

  • Javitt JC and Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Annals of Internal Medicine 124:164–169

    Google Scholar 

  • Klein R, Moss SE, Klein BEK, Davies MD, De Mets LD (1989) The wisconsin epidemiologic study of diabetic retinopathy XI. The incidence of macular edema. Ophthalmology 96: 1501–1510

    Google Scholar 

  • Lienert RT (1989) Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy. Aust NZ J Opththalmol 17:363–368

    Google Scholar 

  • Liu WJ, Lee LT, Yen MF, Tung TH, Williams R et al (2003). Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabet Med 20:727–733

    Article  Google Scholar 

  • Maberley D, Walker H, Koushik A, Cruess A (2003) Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. Can Med Assoc J 2:160–164

    Google Scholar 

  • NHS Centre for Reviews and Dissemination (NHS CRD) (1999) Complications of diabetes: screening for retinopathy. Management of foot ulcers. Effective Health Care Bulletin No. 5. University of York, UK

  • NHS NSC Diabetic Retinopathy Screening (2001) Resources for a national diabetic risk-reduction programme, www.diabetic-retinopathy.screening.nhs.uk/costings.html accessed 13 December 2005

  • Office of Population Censuses and Surveys (1992) Series DH1 No 24, Mortality statistics - general, HMSO, London

  • Polak BCP, Crijns H, Casparie AF, Niessen LW (2003) Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy. Health Policy 64:89–97

    Article  Google Scholar 

  • Pugh JA, Jacobson JM, Van Heuven WA et al (1993) Screening for diabetic retinopathy. The wide angle retinal camera. Diabet Care 16:889–895

    Google Scholar 

  • Rauner MS, Brailsford SC, Flessa S (2005a) The use of discrete-event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries. J Oper Res Soc 56:222–233

    Article  Google Scholar 

  • Rauner MS, Gutjahr WJ, Brailsford SC and Zeppelzauer W (2005b) Optimal screening policies for diabetic retinopathy using a combined discrete-event simulation and ant colony optimization approach. In: Anderson JG, Katzper M (eds) Proceedings of the 2005 international conference on health sciences simulation, Western simulation multiconference 2005, 23–27 January 2005, New Orleans, The Society for Modeling and Simulation International, San Diego pp 147–152

  • Reenders K, de Noble E, van den Hoogen H, van Weel C (1992) Screening for diabetic retinopathy by general practitioners. Scand J Prim Health Care 10:306–309

    Google Scholar 

  • Samanta A, Burden ACm, Fent B (1987) Comparative prevalence of NIDDM in Asian and white Caucasian adults. Diabet Res Clin Pract 4:1–6

    Article  Google Scholar 

  • Torrance GW, Feeny D (1989) Utilities and quality adjusted life years. Int J Technol Assess Health Care 2:559–575

    Article  Google Scholar 

  • Vijan S, Hofer TP, Hayward RA (2000) Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. J Am Med Assoc 283:889–96

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sally C. Brailsford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brailsford, S.C., Gutjahr, W.J., Rauner, M.S. et al. Combined Discrete-event Simulation and Ant Colony Optimisation Approach for Selecting Optimal Screening Policies for Diabetic Retinopathy. CMS 4, 59–83 (2007). https://doi.org/10.1007/s10287-006-0008-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10287-006-0008-x

Keywords

Navigation